Serotype-specific modulation of human monocyte functions by glycopeptidolipid (GPL) isolated from Mycobacterium avium complex.
Immunomodulating activity of glycopeptidolipids (GPL), separated from different serovars of Mycobacterium avium complex (MAC), on macrophage functions was compared. When peripheral blood mononuclear cells (PBMC), from healthy donors showing strongly positive reactions to mycobacterial purified protein derivatives (PPD), were incubated with heat-killed Staphylococcus aureus coated with GPL serovar 4, phagocytosis of monocytes increased in dose-dependent manner. However, coating with GPL serovar 9 did not show any effects. After phagocytosis of heat-killed S. aureus, the phagosome-lysosome (P-L) fusion in monocytes was inhibited dose-dependently by coating of S. aureus with GPL serovar 4, but not serovar 9. These results indicate that GPL serovar 4 facilitates invasion of MAC into monocytes and renders resistance to bactericidal reactions due to the inhibition of P-L fusion. Regarding accessory function of macrophages in proliferative responses of T cells, the addition of GPL serovar 4 to cultures resulted in significant inhibition of anti-CD3 monoclonal antibody (mAb)-induced proliferation, whereas both serovar GPLs did not cause reduction of cell viability. Furthermore, the PPD-specific T cell proliferative response was downregulated markedly by GPL serovar 4, but weakly suppressed by GPL serovar 9. These results indicated that the immunomodulating activity of GPL on macrophage functions is serovar-dependent.
Kano
Hideyuki
H
Department of Bioscience, School of Science and Graduate School of Fundamental Life Science, Kitasato University, Sagamihara 228-8555, Japan.
Doi
Takeshi
T
Fujita
Yukiko
Y
Takimoto
Hiroaki
H
Yano
Ikuya
I
Kumazawa
Yoshio
Y
D004305:Dose-Response Relationship, Drug; D006017:Glycolipids / Q000302:isolation & purification / Q000494:pharmacology*; D006020:Glycopeptides / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D009000:Monocytes / Q000187:drug effects* / Q000502:physiology; D009162:Mycobacterium avium / Q000145:classification* / Q000302:isolation & purification; D010587:Phagocytosis / Q000187:drug effects / Q000502:physiology; D012703:Serotyping / Q000379:methods
D006017:Glycolipids; D006020:Glycopeptides